...
首页> 外文期刊>Clinical Chemistry: Journal of the American Association for Clinical Chemists >Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women
【24h】

Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women

机译:循环性动脉粥样硬化胆固醇质量和脂蛋白颗粒浓度与女性未来冠脉事件的关系

获取原文

摘要

BACKGROUND: It is uncertain whether measurement of circulating total atherogenic lipoprotein particle cholesterol mass [nona??HDL cholesterol (nonHDLc)] or particle concentration [apolipoprotein B (apo B) and LDL particle concentration (LDLp)] more accurately reflects risk of incident coronary heart disease (CHD). We evaluated CHD risk among women in whom these markers where discordant. METHODS: Among 27533 initially healthy women in the Women's Health Study ([NCT00000479][1]), using residuals from linear regression models, we compared risk among women with higher or lower observed particle concentration relative to nonHDLc (highest and lowest residual quartiles, respectively) to individuals with agreement between markers (middle quartiles) using Cox proportional hazards models. RESULTS: Although all 3 biomarkers were correlated ( r a?¥ 0.77), discordance occurred in up to 20.2% of women. Women with discordant high particle concentration were more likely to have metabolic syndrome (MetS) and diabetes (both P 0.001). Over a median follow-up of 20.4 years, 1246 CHD events occurred (514725 person-years). Women with high particle concentration relative to nonHDLc had increased CHD risk: age-adjusted hazard ratio (95% CI) = 1.77 (1.56a??2.00) for apo B and 1.70 (1.50a??1.92) for LDLp. After adjustment for clinical risk factors including MetS, these risks attenuated to 1.22 (1.07a??1.39) for apo B and 1.13 (0.99a??1.29) for LDLp. Discordant low apo B or LDLp relative to nonHDLc was not associated with lower risk. CONCLUSIONS: Discordance between atherogenic particle cholesterol mass and particle concentration occurs in a sizeable proportion of apparently healthy women and should be suspected clinically among women with cardiometabolic traits. In such women, direct measurement of lipoprotein particle concentration might better inform CHD risk assessment. [1]: /lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00000479&atom=%2Fclinchem%2F63%2F4%2F870.atom
机译:背景:循环总动脉粥样硬化脂蛋白颗粒胆固醇质量[nona ?? HDL胆固醇(nonHDLc)]或颗粒物浓度[载脂蛋白B(apo B)和LDL颗粒物浓度(LDLp)]的测量是否更准确地反映了发生冠状动脉的风险尚不确定心脏病(CHD)。我们评估了这些标志不一致的女性中的冠心病风险。方法:在《妇女健康研究》([NCT00000479] [1])中的27533名最初健康的妇女中,使用线性回归模型的残差,我们比较了相对于非HDLc(最高和最低残差四分位数,使用Cox比例风险模型在标记(中间四分位数)之间达成一致的个体。结果:尽管所有3种生物标志物均相关(相关系数为0.77),但高达20.2%的女性出现不一致。高颗粒浓度不一致的女性更容易发生代谢综合症(MetS)和糖尿病(P <0.001)。在20.4年的中位数随访中,发生了1246次CHD事件(514725人年)。相对于非HDLc而言,高颗粒浓度的女性患CHD的风险增加:载脂蛋白B的年龄调整后的危险比(95%CI)= 1.77(1.56a ?? 2.00)和LDLp 1.70(1.50a ?? 1.92)。在对包括MetS在内的临床风险因素进行调整后,载脂蛋白B的风险降低至1.22(1.07a ?? 1.39),低密度脂蛋白的风险降至1.13(0.99a ?? 1.29)。相对于非HDLc,不一致的低apo B或LDLp与较低的风险无关。结论:动脉粥样硬化胆固醇水平和胆固醇浓度之间的不一致发生在相当比例的显然健康的女性中,在具有心脏代谢特征的女性中应在临床上怀疑。在此类女性中,直接测量脂蛋白颗粒浓度可能会更好地指导冠心病风险评估。 [1]:/lookup/external-ref?link_type=CLINTRIALGOV&access_num=NCT00000479&atom=%2Fclinchem%2F63%2F4%2F870.atom

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号